Substudy (secondary analysis) of a cluster-randomised malaria trial in Mozambique, 1951 participants: ivermectin mass drug administration lowered scabies prevalence at 3 months vs albendazole (2.11% vs 13.71%; aOR 0.18), including in untreated children under 5.
Secondary analysisn = 1,951
Furnival-Adams et al. Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trial